title: Ritonavir enables combined therapy with rifampin and saquinavir.
authors.affiliation: Slotervaart Hospital, Department of Pharmacy and Pharmacology, 1066 EC Amsterdam, The Netherlands. APABG@SLZ.NL
authors.forename: A I
authors.initials: AI
authors.lastname: Veldkamp
authors.forename: R M
authors.initials: RM
authors.lastname: Hoetelmans
authors.forename: J H
authors.initials: JH
authors.lastname: Beijnen
authors.forename: J W
authors.initials: JW
authors.lastname: Mulder
authors.forename: P L
authors.initials: PL
authors.lastname: Meenhorst
mesh_terms: D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D012293:Rifampin / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D019258:Saquinavir / Q000493:pharmacokinetics / Q000627:therapeutic use; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy
chemical_list: D004791:Enzyme Inhibitors; D017320:HIV Protease Inhibitors; D019258:Saquinavir; D019438:Ritonavir; D012293:Rifampin